About Gail Maderis
Form D filings for Antiva Biosciences from 2017 to 2024 list Gail Maderis as director.
Gail Maderis first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Gail Maderis in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Gail Maderis works with at each company, as listed on that company's latest Form D.
Antiva Biosciences, Inc. · Form D/A, Oct 11, 2024
CS
Clifford Samuel
Director
BR
Beni Rovinski
Director
FS
Florencia Segal
Director
KB
Kristine Ball
Chief Executive Officer and director
EC
Elaine Chien
Executive officer
BG
Brian Goodman
Director
WH
Wende Hutton
Director
SW
Sarah Walter
Executive officer
RG
Raju Gadiraju
Executive officer